US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INVESCO PHARMACEUTICALS ETF

120.88

-0.3600-0.30%

Post-market: 120.880.00000.00%19:30 EDT

Volume:21.60K

Turnover:2.61M

Market Cap:545.17M

PE:6.27

High:121.66

Open:121.66

Low:120.55

Close:121.24

52wk High:131.68

52wk Low:92.10

Shares:4.51M

Float Shares:4.51M

Volume Ratio:0.46

T/O Rate:0.48%

Dividend:1.11

Dividend Rate:0.92%

EPS(TTM):19.29

EPS(LYR):21.73

ROE:23.89%

ROA:0.60%

PB:1.64

PE(LYR):5.56

Loading ...

Overview Company News Filings

Johnson & Johnson says Tremfya met endpoints in Phase 4 STAR study

J&J - Star Study Shows Tremfya Safety Profile Consistent with Psa; no New Safety Signals

THOMSON REUTERS

J&J - Tremfya Meets Primary Endpoint for Basdai Score Improvement at Week 24

THOMSON REUTERS

J&J - Tremfya Meets Primary and Major Secondary Endpoints in Axial Psa Study

THOMSON REUTERS

Johnson & Johnson Announces Tremfya® (Guselkumab) is the First and Only Il-23 Inhibitor to Show Significant Improvement in Spinal Pain and Stiffness in Landmark Axial Psoriatic Arthritis (Psa) Study

THOMSON REUTERS

Single Infusion of Carvykti Delivered Five-Year Treatment-Free Remissions in 50% of Patients in Early Line Relapsed/Refractory Multiple Myeloma

Nektar Therapeutics - Jury Finds Lilly Breached Implied Covenant of Good Faith in License Agreement - SEC Filing

THOMSON REUTERS

J&J - Carvykti Delivers Five-Year Treatment-Free Remissions in 50% of Early Line Rrmm Patients

THOMSON REUTERS

J&J - Five-Year Overall Survival Rate 69.2%, Median Progression-Free Survival 60.5 Months

THOMSON REUTERS

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Amgen (AMGN) and Imunon (IMNN)

Estee Lauder Cos. Cl a Stock Underperforms Thursday When Compared to Competitors

Agilent Technologies Inc. Stock Outperforms Competitors on Strong Trading Day

Nanobiotix advances cancer nanotherapeutics and bolsters cash runway into 2029

France's Nanobiotix H1 Net Loss Widens on Lower Revenue, Absence of 2025 One-Off Gain

Press Release: Nanobiotix Provides First Half 2026 Operational and Financial Update

Oruka Therapeutics' Psoriasis Treatment Maintains 'Competitive Profile' After Positive Clinical Data, UBS Says

MT Newswires Live

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

FDA Advisors Said it Should Approve the Grail Multicancer Blood Test. the Stock Rises Sharply.

Eli Lilly and Co Stock (LLY) Moved Up by 3.73% on Sep 24: A Full Analysis

Lilly's Next-Gen Obesity Efforts Could Tip Scales Further in Its Favor, Citi Says

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/PJP/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PJP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PJP\",,,,,undefined,":{"symbol":"PJP","market":"US","secType":"STK","nameCN":"INVESCO PHARMACEUTICALS ETF","latestPrice":120.88,"timestamp":1790971200000,"preClose":121.24,"halted":0,"volume":21601,"hourTrading":{"tag":"盘后","latestPrice":120.88,"preClose":120.88,"latestTime":"19:30 EDT","volume":14,"amount":1692.28,"timestamp":1790983802888,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.002969317057076868,"floatShares":4510000,"shares":4510000,"eps":19.286062,"marketStatus":"Market Closed","change":-0.36,"latestTime":"10-02 16:00:00 EDT","open":121.66,"high":121.66,"low":120.55,"amount":2612851.99177,"amplitude":0.009155,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":19.286062,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":121.24,"sharesOutstanding":3870000,"nav":121.31214,"aum":543994063.98,"dividendRate":0.009191,"bidAskSpread":0.000936,"preHourTrading":{"tag":"盘前","latestPrice":121.24,"preClose":121.24,"latestTime":"08:20 EDT","volume":3,"amount":363.71999999999997,"timestamp":1790943636164,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":120.88,"preClose":120.88,"latestTime":"19:30 EDT","volume":14,"amount":1692.28,"timestamp":1790983802888,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.4558769543236467,"impliedVol":0.0545,"impliedVolPercentile":0.1315},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PJP\",,,,,undefined,":{"symbol":"PJP","floatShares":4510000,"roa":"0.60%","roe":"23.89%","lyrEps":21.734944,"volumeRatio":0.4558769543236467,"shares":4510000,"dividePrice":1.111031,"high":121.66,"amplitude":0.009155,"preClose":121.24,"low":120.55,"week52Low":92.095,"pbRate":"1.64","psRate":"107.56","week52High":131.675,"institutionHeld":0.824,"latestPrice":120.88,"eps":19.286062,"divideRate":0.009191,"volume":21601,"delay":0,"ttmEps":19.286062,"open":121.66,"prevYearClose":104.54,"prevWeekClose":126.82,"prevMonthClose":123.31,"prevQuarterClose":123.31,"fiveDayClose":126.82,"twentyDayClose":129.59,"sixtyDayClose":120.4458},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PJP\",params:#limit:5,,,undefined,":[{"date":"2026-09-21","symbol":"PJP","amount":0.30136,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-21","defaultRemindTime":1789997400000,"name":"INVESCO PHARMACEUTICALS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-25","payableDate":"2026-09-21","currency":"USD","dateTimestamp":1789963200000,"payDate":"2026-09-25"},{"date":"2026-06-22","symbol":"PJP","amount":0.27334,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"INVESCO PHARMACEUTICALS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"PJP","amount":0.30902,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"INVESCO PHARMACEUTICALS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"PJP","amount":0.24629,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"INVESCO PHARMACEUTICALS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"PJP","amount":0.23633,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"INVESCO PHARMACEUTICALS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PJP\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.20736,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-31","value":0.03683,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-30","value":0.15586,"currency":"USD"},{"executeDate":"2017-09-18","recordDate":"2017-09-19","paymentDate":"2017-09-29","value":0.12281,"currency":"USD"},{"executeDate":"2018-03-19","recordDate":"2018-03-20","paymentDate":"2018-03-29","value":0.05634,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PJP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PJP\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2670427334","title":"Johnson & Johnson says Tremfya met endpoints in Phase 4 STAR study","url":"https://stock-news.laohu8.com/highlight/detail?id=2670427334","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670427334?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:35","pubTimestamp":1790336153,"startTime":"0","endTime":"0","summary":"Johnson & Johnson announced that Tremfya met the primary and major secondary endpoints demonstrating both improvement in axial symptoms and reducti...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/johnson-johnson-says-tremfya-met-endpoints-in-phase-4-star-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/johnson-johnson-says-tremfya-met-endpoints-in-phase-4-star-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1221951129.SGD","JDOC","IXJ","LU1261432733.SGD","LU1244550494.USD","PJP","GDOC","LU0098860793.USD","LU1228905037.USD","LU1894683264.USD","LU0738911758.USD","LU1496350502.SGD","LU1674673428.USD","IHE","LU1732799900.SGD","SGXZ57979304.SGD","IE00BFTCPJ56.SGD","VHT","XLV","FTXH","LU0820561909.HKD","MEDX","BK4568","LU1196500208.SGD","LU1551013342.USD","LU1145028129.USD","JNJ","SG9999002224.SGD","FHLC","TRUH","BMED","LU1280957306.USD","LU0889566641.SGD","LU1066051498.USD","IE00BKVL7J92.USD","IE000M9KFDE8.USD","LU1066053197.SGD","IE00BLSP4239.USD","LU0661504455.SGD","IE00BZ1G4Q59.USD","LU0289961442.SGD","LU0820562030.AUD","IYH","LU0203347892.USD","LU1003077747.HKD","LU1032955483.USD","RXL","BK4559","LU0234570918.USD","LU1057294990.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670444217","title":"J&J - Star Study Shows Tremfya Safety Profile Consistent with Psa; no New Safety Signals","url":"https://stock-news.laohu8.com/highlight/detail?id=2670444217","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670444217?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:30","pubTimestamp":1790335800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nTUA659LC0:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0002141913.USD","IYH","IHE","LU2750360997.AUD","MEDX","JNJ","LU0069063385.USD","LU2487616109.SGD","XLV","LU0162691827.USD","LU2592432038.USD","LU0943347566.SGD","LU1585245621.USD","TRUH","JDOC","GDOC","LU0124676726.USD","LU2347655156.SGD","BMED","LU2236285917.USD","LU1043141123.HKD","LU1162221912.USD","IE0034235303.USD","LU1145028129.USD","IE000WAW04H5.SGD","LU0203347892.USD","VHT","LU0738911758.USD","PJP","LU1732799900.SGD","LU2430703095.HKD","LU1074936037.SGD","LU1506573853.SGD","IE00B19Z3B42.SGD","LU1023059063.AUD","LU0466842654.USD","IE0009355771.USD","LU1496350502.SGD","LU2129689431.USD","FTXH","FHLC","LU1244550577.SGD","BK4534","IXJ","IE00B19Z3581.USD","RXL","IE00BFTCPJ56.SGD","LU2750360641.GBP","LU0882574055.USD","LU0820561818.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670442175","title":"J&J - Tremfya Meets Primary Endpoint for Basdai Score Improvement at Week 24","url":"https://stock-news.laohu8.com/highlight/detail?id=2670442175","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670442175?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:30","pubTimestamp":1790335800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nTUA659LC0:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1894683348.USD","LU2430703095.HKD","MEDX","IHE","LU0203345920.USD","IE0034235303.USD","LU2430703178.SGD","LU0210536198.USD","LU1032955483.USD","FTXH","IXJ","BMED","JDOC","IE000MB6IJN5.SGD","IE00BGHQF631.EUR","LU0234570918.USD","GDOC","TRUH","LU0882574055.USD","LU0689626769.HKD","VHT","LU2133065610.SGD","IYH","LU0912757837.SGD","LU1629891620.HKD","BK4559","LU0057025933.USD","FHLC","IE00BLSP4452.SGD","LU2896262040.SGD","PJP","RXL","LU0820562030.AUD","LU0289739699.SGD","LU0472753341.HKD","LU1989771016.USD","XLV","LU0345769128.USD","JNJ","IE00B4R5TH58.HKD","SG9999002232.USD","LU2471134952.CNY","LU1732800096.USD","LU1066051225.USD","LU1280957306.USD","LU2112291526.USD","LU2471134523.USD","LU2602419157.SGD","BK4592","LU1506573853.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670442172","title":"J&J - Tremfya Meets Primary and Major Secondary Endpoints in Axial Psa Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2670442172","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670442172?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:30","pubTimestamp":1790335800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nTUA659LC0:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2129689514.USD","LU1291159041.SGD","JDOC","LU1043141396.HKD","IE00B19Z3581.USD","LU2750360997.AUD","LU1162221912.USD","LU2602419157.SGD","LU1023059063.AUD","LU1894683348.USD","IE0000B7K699.USD","LU0234572021.USD","LU2471134796.USD","XLV","IE00B3PB1722.GBP","IE000F7OJYX1.SGD","LU2023250330.USD","BK4588","LU0320765646.SGD","MEDX","LU1066051225.USD","LU0820561909.HKD","IE00B4R5TH58.HKD","LU0345770308.USD","LU1244550494.USD","LU2471134523.USD","RXL","VHT","IXJ","IE00BLSP4239.USD","LU2089984988.USD","PJP","LU1228905037.USD","GDOC","LU0640476718.USD","IE00BGHQF631.EUR","LU0210528500.USD","BMED","FHLC","TRUH","LU1430594728.SGD","IYH","SG9999001176.USD","FTXH","LU0466842654.USD","IHE","JNJ","IE00BJJMRZ35.SGD","LU0345769128.USD","LU2417539215.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670421704","title":"Johnson & Johnson Announces Tremfya® (Guselkumab) is the First and Only Il-23 Inhibitor to Show Significant Improvement in Spinal Pain and Stiffness in Landmark Axial Psoriatic Arthritis (Psa) Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2670421704","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670421704?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:30","pubTimestamp":1790335800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nTUA659LC0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2089984988.USD","BK4559","VHT","XLV","LU1914381329.SGD","IHE","LU1244550577.SGD","LU1032466523.USD","FHLC","TRUH","LU0320765646.SGD","LU2403377893.USD","MEDX","IE000M9KFDE8.USD","IE00B19Z3B42.SGD","LU2756315318.SGD","SGXZ80539844.SGD","LU0345770993.USD","IE000MB6IJN5.SGD","IE00BJJMRZ35.SGD","IYH","LU1066053197.SGD","JDOC","LU1196500208.SGD","BK4007","LU0122379950.USD","RXL","SGXZ57979304.SGD","BK4568","LU0162691827.USD","LU2896262040.SGD","BMED","IE00BBT3K403.USD","LU2236285917.USD","PJP","BK4532","LU0661504455.SGD","LU0289961442.SGD","BK4588","LU0949170772.SGD","LU1066051225.USD","LU1929549753.HKD","LU0098860793.USD","IXJ","JNJ","LU1551013342.USD","FTXH","LU0820561818.USD","IE0001KFT4U8.USD","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670442334","title":"Single Infusion of Carvykti Delivered Five-Year Treatment-Free Remissions in 50% of Patients in Early Line Relapsed/Refractory Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2670442334","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670442334?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:02","pubTimestamp":1790334153,"startTime":"0","endTime":"0","summary":"BRIEF-Single Infusion Of Carvykti Delivered Five-Year Treatment-Free Remissions In 50% Of Patients In Early Line Relapsed/Refractory Multiple MyelomaSept 25 (Reuters)-Johnson & JohnsonJNJ.N:SINGLE INF","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nFWN45G1G2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B1BXHZ80.USD","IE00BBT3K403.USD","LU0345769128.USD","GDOC","VHT","LU0545039389.USD","LU0943347566.SGD","SG9999001440.SGD","IE00BLSP4452.SGD","LU1496350502.SGD","FTXH","LU1894683348.USD","LU0689626769.HKD","LU0882574055.USD","PJP","RXL","IE00BFXG1179.USD","IE00B3T34201.USD","IXJ","LU0545562505.USD","JNJ","LU0426417589.USD","LU2602419157.SGD","BK4568","IE00B19Z3581.USD","LU0124676726.USD","IYH","SGXZ57979304.SGD","LU1228905540.USD","LU0689472784.USD","MEDX","LU0057025933.USD","LU0511384066.AUD","BK4588","BMED","LU2213496289.HKD","LU0640476718.USD","IE000WAW04H5.SGD","LU0345770308.USD","LU1032955483.USD","IE0002270589.USD","LU1196500208.SGD","IE00BGHQF631.EUR","IE00BN8TJ469.HKD","LU0072461881.USD","IHE","JDOC","XLV","TRUH","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670442878","title":"Nektar Therapeutics - Jury Finds Lilly Breached Implied Covenant of Good Faith in License Agreement - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2670442878","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670442878?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:01","pubTimestamp":1790334099,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nFWN45G1D3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999015952.SGD","LU2461242641.AUD","LU1868837136.USD","LU0323591593.USD","LU2237443978.SGD","LU0109391861.USD","LU2063271972.USD","ILDR","LU2237443549.SGD","OZEM","IE00BJJMRY28.SGD","LU0061475181.USD","IE0001KFT4U8.USD","IE00B7KXQ091.USD","LU2237443622.USD","LU2271345857.HKD","IE00BKPKM429.USD","IXJ","LU0210536198.USD","LU1629891620.HKD","LU0823416689.USD","LU2552382215.SGD","LU2602419157.SGD","LU1988902786.USD","LU0203202063.USD","LU1366192091.USD","LU1974910355.USD","LU0640476718.USD","LU2023250330.USD","FTXH","LU2089283258.USD","BK4534","MHIP","LU2211815571.USD","LU1868836757.USD","LU0266013472.USD","LU1814569148.SGD","LU2168564222.USD","LU1979441026.SGD","IYH","LU1267930730.SGD","SG9999015945.SGD","IE00BKDWB100.SGD","SG9999015986.USD","LU1989771016.USD","LU2756315318.SGD","LU1868836591.USD","LU2361044949.HKD","LU2237443895.HKD","IE00BJJMRX11.SGD","LU1548497426.USD","CANC","LU2237438978.USD","LU0823434583.USD","LU0353189680.USD","MEDX","LU2357305700.SGD","LU0122379950.USD","LU0096364046.USD","LU0786609619.USD","SGXZ99366536.SGD","IE00B4R5TH58.HKD","SG9999001176.SGD","BK4007","IE00BFSS8Q28.SGD","IE00BK4W5M84.HKD","LU2361044865.SGD","IE00B1BXHZ80.USD","IE00BFSS7M15.SGD","LU0320765059.SGD","LU1023059063.AUD","LU2462591350.SGD","LLII","LU0316494557.USD","LU0820561909.HKD","TRUH","WDNA","IE00B1XK9C88.USD","LU1551013425.SGD","BK4516","LU1035775433.USD","LU2237443465.HKD","LU1069344957.HKD","IE00BN29S564.USD","LU1057294990.SGD","LU2168564065.EUR","LU0006306889.USD","LU0385154629.USD","BK4581","LU2168563687.JPY","LU2028103732.USD","SG9999001176.USD","LU2168564149.EUR","LU1280957306.USD","LU1093756325.SGD","LLYZ","IE00BJLML261.HKD","LU2462157665.USD","SGXZ51526630.SGD","LU2471134523.USD","LU0225283273.USD","LU0689472784.USD","LU1127390331.HKD","NKTR","FHLC","LU1691799644.USD","LU0787776722.HKD","PJP","LU0320765992.SGD","LU1064131342.USD","JDOC","LU2756315664.SGD","LU2896262040.SGD","LU2471134879.HKD","IE0004445015.USD","SGXZ31699556.SGD","LU0672654240.SGD","LU1323610961.USD","LU2417539215.USD","LU0289739699.SGD","LU2168564495.EUR","LU0820562030.AUD","LU2468319806.SGD","LU2264538146.SGD","SG9999014914.USD","IE00B2B36J28.USD","LU0823434740.USD","GDOC","LU0708995401.HKD","IE00BJT1NW94.SGD","LU0354030511.USD","LU1061106388.HKD","IE0005OL40V9.USD","LU0882574055.USD","BK4585","LU2491050154.USD","LU0432979614.USD","IE00BWXC8680.SGD","SG9999015978.USD","SG9999018865.SGD","LU2491050071.SGD","LU0198837287.USD","LU2265009873.SGD","HRTS","LU1551013342.USD","LU0106261372.USD","SG9999013999.USD","LU0256863902.USD","LU0964807845.USD","AGNG","SG9999014880.SGD","BK4588","LU0889565916.HKD","IE00B4JS1V06.HKD","LU2023251221.USD","SG9999017495.SGD","LU1623119135.USD","LU0471298777.SGD","LU2106854487.HKD","LU2108987350.USD","LU0079474960.USD","LU2746668461.USD","VHT","LU2750360997.AUD","LU0353189763.USD","LU1720051108.HKD","LU0471298694.HKD","LU0109394709.USD","LU0114720955.EUR","SG9999014906.USD","LU0174119429.USD","SG9999018857.SGD","LU2023250504.SGD","IHE","LU1145028129.USD","BK4599","ELIL","LU1093756168.USD","LU0094547139.USD","IE0004445239.USD","LU0456855351.SGD","LU2324357040.USD","LU2491049909.HKD","LU0354030438.USD","RXL","LU2552382132.HKD","LU0238689110.USD","LU2089284900.SGD","IE00BK4W5L77.USD","LU2750360641.GBP","LU0417517546.SGD","THNR","ELIS","LU0158827948.USD","LU1868837300.USD","LU2111349929.HKD","LU0058720904.USD","TMED","LLYX","IE00BFTCPJ56.SGD","GB00BDT5M118.USD","SGXZ57979304.SGD","LU0466842654.USD","LU0882574139.USD","LU1291159041.SGD","LU1917777945.USD","LU1983299246.USD","LU0158827781.USD","LU2237443382.USD","LU2361045086.USD","LU2746668974.SGD","LU0256863811.USD","LU0820561818.USD","BK4533","LU0097036916.USD","IE00B775H168.HKD","LU2456880835.USD","LU2213496289.HKD","LLY","LU1804176565.USD","LU1712237335.SGD","LU0943347566.SGD","LU0133085943.USD","XLV","LU0234572021.USD","LU1232071149.USD","LU0683600562.USD","LU2112291526.USD","SG9999014898.SGD","IE0002141913.USD","LU0203201768.USD","IE00BJJMRZ35.SGD","PPH","CURE","MEDI","LU2471134952.CNY","SGXZ81514606.USD","LU2087625088.SGD","LU2360106947.USD","LU1868836914.USD","LU2089984988.USD","LU2471134796.USD","IE0009355771.USD","LU0345770308.USD","LU1720051017.SGD","LU2236285917.USD","LU2552382058.USD","LU0345770993.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670444072","title":"J&J - Carvykti Delivers Five-Year Treatment-Free Remissions in 50% of Early Line Rrmm Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2670444072","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670444072?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:00","pubTimestamp":1790334004,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nFWN45G1G2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0426417589.USD","MEDX","IE00BVYPNV92.GBP","BMED","LU0124676726.USD","IHE","LU0820561909.HKD","LU0787776722.HKD","LU1244550221.USD","GDOC","IE00BSNM7G36.USD","LU0203347892.USD","LU0738911758.USD","SG9999002232.USD","LU0820562030.AUD","IYH","IE00BJJMRZ35.SGD","LU0072461881.USD","LU1121112475.USD","BK4592","FTXH","LU2112291526.USD","FHLC","LU2471134796.USD","IE000WAW04H5.SGD","IE00B2B36J28.USD","LU1057294990.SGD","LU2471134523.USD","BK4559","PJP","JDOC","LU1043141396.HKD","JNJ","XLV","LU1894683264.USD","LU1066051811.HKD","LU1261432733.SGD","TRUH","RXL","LU0069063385.USD","LU0234570918.USD","LU1280957306.USD","LU0553294199.USD","LU2089984988.USD","VHT","IXJ","LU0949170772.SGD","LU0070217475.USD","BK4581","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670440474","title":"J&J - Five-Year Overall Survival Rate 69.2%, Median Progression-Free Survival 60.5 Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2670440474","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670440474?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:00","pubTimestamp":1790334004,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nFWN45G1G2:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1894683348.USD","MEDX","LU0345770993.USD","IE00BFXG1179.USD","BK4532","IHE","IE00BDGV0183.EUR","IE00BBT3K403.USD","LU0210536198.USD","FTXH","IXJ","IE00BKVL7J92.USD","JDOC","BMED","GDOC","LU0426412945.USD","LU0738911758.USD","LU0289961442.SGD","LU0949170772.SGD","TRUH","LU0689472784.USD","LU0511384066.AUD","LU2750360641.GBP","VHT","IYH","BK4585","LU0098860793.USD","LU2023250330.USD","FHLC","LU0985320562.USD","PJP","LU0545562505.USD","LU1196500208.SGD","LU2129689431.USD","RXL","LU1032466523.USD","SG9999013999.USD","LU0553294199.USD","LU1989771016.USD","XLV","LU1674673691.USD","JNJ","LU1732799900.SGD","LU0122379950.USD","LU2505996681.GBP","LU1261432733.SGD","LU1280957306.USD","LU1043141123.HKD","IE00BN8TJ469.HKD","LU2347655156.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670466074","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Amgen (AMGN) and Imunon (IMNN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670466074","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670466074?lang=en_us&edition=fundamental","pubTime":"2026-09-25 16:10","pubTimestamp":1790323817,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (AMGN) and Imunon (IMNN). Amgen (AMGN) In a ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-amgen-amgn-and-imunon-imnn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-amgen-amgn-and-imunon-imnn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","SG9999001440.SGD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU0320765992.SGD","LU2089984988.USD","LU2242652126.USD","BK4566","LU0868494617.USD","BBH","LU0029874061.USD","BK4137","BK4599","IE00BFTCPJ56.SGD","LU1571399168.USD","BIB","LU1983299246.USD","IMNN","LU2112291526.USD","IBB","BK4585","XLV","BK4534","LU0058720904.USD","IE0002141913.USD","BK4533","BK4588","BK4581","HCSG","LU0289739699.SGD","LU1061106388.HKD","XBI","IE00B4R5TH58.HKD","AMGN","IE0009355771.USD","LU0128526141.USD","LU0109394709.USD","LU0122379950.USD","LU2468319806.SGD","BK4139","LU1057294990.SGD","PJP","LU2242646821.SGD","LABU","TBXU","PBE","IBBQ","IE00BJT1NW94.SGD","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670413314","title":"Estee Lauder Cos. Cl a Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2670413314","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670413314?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:55","pubTimestamp":1790283300,"startTime":"0","endTime":"0","summary":"DJ Estee Lauder Cos. Cl A Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Estee Lauder Cos. Cl A  slipped 3.50% to $95.37 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.02% to 7,704.13 and Dow Jones Industrial Average  falling 0.31% to 51,349.98.This was the stock's second consecutive day of losses.Estee Lauder Cos. Cl A closed 21.59% below its 52-week high of $121.64, which the company reached on February 3rd.The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson  rose 0.56% to $270.68, Procter & Gamble Co.  fell 1.16% to $145.68, and Coty Inc. Cl A  fell 0.38% to $2.63.Trading volume  eclipsed its 50-day average volume of 3.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 24, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU1066051811.HKD","LU0738911758.USD","JDOC","LU2264538146.SGD","LU1585245621.USD","LU1043141396.HKD","PG","TRUH","IE00BFTCPJ56.SGD","FSTA","SG9999014542.SGD","BK4533","MEDX","EL","RXL","BMED","GLAM","LU2347655156.SGD","LU2592432038.USD","LU1674673428.USD","IE00BBT3K403.USD","IE0034235303.USD","LU0553294199.USD","LU0942090050.USD","PJP","IE00BSNM7G36.USD","LU0057025933.USD","XLP","IHE","LU1914381329.SGD","FTXH","XLV","GDOC","IE00B1XK9C88.USD","IYH","LU0795875169.SGD","FHLC","LU2750360641.GBP","VHT","COTY","SG9999014575.USD","LU2552382132.HKD","TRUO","IE000BZT7R73.USD","LU0114720955.EUR","JNJ","UGE","IXJ","IE000MB6IJN5.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670133894","title":"Agilent Technologies Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2670133894","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670133894?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:52","pubTimestamp":1790283120,"startTime":"0","endTime":"0","summary":"DJ Agilent Technologies Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Agilent Technologies Inc.  advanced 4.55% to $172.84 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.02% to 7,704.13 and Dow Jones Industrial Average  falling 0.31% to 51,349.98.Agilent Technologies Inc. hit a new 52-week high, surpassing its previous peak of $168.94, which the company achieved on September 23rd.The stock outperformed some of its competitors Thursday, as Thermo Fisher Scientific Inc.  rose 1.97% to $678.39, Danaher Corp.  rose 1.00% to $223.77, and Abbott Laboratories  fell 2.34% to $101.07.Trading volume  eclipsed its 50-day average volume of 2.3 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 24, 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TMED","GNMX","LU1623119135.USD","LU0289739343.SGD","LU2092937221.SGD","LU2413666699.HKD","LU2229751404.USD","SGXZ41872573.SGD","IE000M9KFDE8.USD","TMO","LU1551013425.SGD","BK4504","LU0211331839.USD","LU0557290698.USD","LU0234572021.USD","LU0097036916.USD","LU2298321311.HKD","IE00BFTCPJ56.SGD","BK4567","LU0289960550.SGD","LU1923621640.USD","IE00BZ1G4Q59.USD","HRTS","IE00B19Z8W00.USD","LU1721428933.USD","LU1670627923.USD","DHR","IE00BJT1NW94.SGD","ABT","LU2089279066.USD","LU2413666426.HKD","BK4121","IE00B1BXHZ80.USD","LU0432979614.USD","PJP","LU1804176565.USD","LU1983299246.USD","LU0107464264.USD","BK4533","LU0011850046.USD","LU0345770993.USD","BK4082","IHI","LU2264538146.SGD","LU0310800379.SGD","FMED","A","LU0208291251.USD","IE00BQXX3D17.EUR","LU0029864427.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670187634","title":"Nanobiotix advances cancer nanotherapeutics and bolsters cash runway into 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2670187634","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670187634?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:32","pubTimestamp":1790281948,"startTime":"0","endTime":"0","summary":"Nanobiotix ( ($FR:NANO) ) just unveiled an announcement. Nanobiotix reported encouraging clinical progress for its lead nanoradioenhancer JNJ-1900 ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nanobiotix-advances-cancer-nanotherapeutics-and-bolsters-cash-runway-into-2029?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nanobiotix-advances-cancer-nanotherapeutics-and-bolsters-cash-runway-into-2029?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","GDOC","LU1585245621.USD","BMED","IE000SO60NU8.SGD","LU0738911758.USD","BK4007","RXL","LU1914381329.SGD","LU0820562030.AUD","LU0234572021.USD","LU2089984988.USD","LU0098860793.USD","LU2750360641.GBP","LU0466842654.USD","LU1066051811.HKD","LU1244550494.USD","IYH","LU0640476718.USD","NANO","TRUH","LU0053666078.USD","LU2471134523.USD","MEDX","LU2471134952.CNY","LU2756315664.SGD","LU2756315318.SGD","FHLC","IXJ","LU0070217475.USD","SG9999001440.SGD","PJP","LU2129689605.HKD","VHT","XLV","JNJ","IE00BDGV0183.EUR","LU0057025933.USD","JDOC","LU2505996681.GBP","LU0795875169.SGD","IE00BLSP4452.SGD","IE000WAW04H5.SGD","IE00B3T34201.USD","IHE","LU2430703178.SGD","FTXH","LU0122379950.USD","LU2133065610.SGD","LU1894683348.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670941892","title":"France's Nanobiotix H1 Net Loss Widens on Lower Revenue, Absence of 2025 One-Off Gain","url":"https://stock-news.laohu8.com/highlight/detail?id=2670941892","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670941892?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:24","pubTimestamp":1790281482,"startTime":"0","endTime":"0","summary":"France's Nanobiotix H1 net loss widens on lower revenue, absence of 2025 one-off gainOverviewFrance-based biotech firm's H1 2026 revenue declined due to prior year one-off non-cash impactNet loss wide","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nL1N45G12R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0210528500.USD","LU2089984988.USD","VHT","XLV","IHE","LU2750360997.AUD","LU0072461881.USD","SG9999001176.SGD","LU0345769128.USD","FHLC","LU1032466523.USD","TRUH","LU1121112475.USD","MEDX","LU1221951046.USD","LU0345769631.USD","LU0792757196.USD","IYH","LU1506573853.SGD","JDOC","LU2112291526.USD","LU2430703251.USD","LU0545039389.USD","RXL","IE00B19Z3581.USD","LU0114720955.EUR","LU0162691827.USD","IE000WAW04H5.SGD","SGXZ57979304.SGD","LU2896262040.SGD","BMED","PJP","LU1496350502.SGD","LU0795875086.SGD","LU0289961442.SGD","BK4588","LU0949170772.SGD","IE0000B7K699.USD","LU1057294990.SGD","LU1162221912.USD","IE00BGHQF631.EUR","LU0889566641.SGD","IE00B4R5TH58.HKD","IXJ","JNJ","LU0098860793.USD","FTXH","IE0001KFT4U8.USD","GDOC","LU0053666078.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670418519","title":"Press Release: Nanobiotix Provides First Half 2026 Operational and Financial Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2670418519","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670418519?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:15","pubTimestamp":1790280900,"startTime":"0","endTime":"0","summary":"-- Promising early results reported from full cohort analysis of the. completed dose-escalation and expansion phases of a Phase 1 study. recurrent non-small cell lung cancer  amenable to re-irradiation. -- Strengthened financial position through an oversubscribed EUR86 million. global follow-on offering completed in May 2026, extending cash runway. -- Acceptable safety profile and promising initial efficacy responses. observed in Johnson & Johnson-led Phase 2 CONVERGE study evaluating. Phase 3 NANORAY-312 study evaluating JNJ-1900  in locally. Anderson Cancer Center  presented at 2026 WCLC Meeting:. control rate was 79%. One-year local progression-free survival.  was 61%, and one-year overall survival  was 70% in. clinically meaningful local control using a substantially lower. -- All 24 patients completed treatment with JNJ-1900  plus","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1244550577.SGD","IE00BN8TJ469.HKD","BK4534","LU0234570918.USD","BK4139","LU1629891620.HKD","TRUH","IE00BVYPNW00.USD","JDOC","IE000SO60NU8.SGD","BK4559","SGXZ80539844.SGD","VHT","SG9999001176.SGD","JNJ","RXL","LU1066051225.USD","IYH","LU2756315664.SGD","IXJ","MEDX","SG9999001440.SGD","LU0994945656.USD","FHLC","LU0057025933.USD","IHE","LU0210528500.USD","PJP","LU1551013342.USD","LU0738911758.USD","LU0289739343.SGD","NBTX","SG9999001176.USD","SG9999013999.USD","LU0345769631.USD","LU0689472784.USD","LU1989771016.USD","GDOC","LU0345770308.USD","LU1894683264.USD","BK4007","XLV","LU0912757837.SGD","LU1674673428.USD","BMED","LU0234572021.USD","FTXH","IE00B19Z3581.USD","BK4532","BK4592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670492787","title":"Oruka Therapeutics' Psoriasis Treatment Maintains 'Competitive Profile' After Positive Clinical Data, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2670492787","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670492787?lang=en_us&edition=fundamental","pubTime":"2026-09-25 01:02","pubTimestamp":1790269368,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics'  lead program of long-acting IL-23 in moderate-to-severe psoriasis maintains a \"competitive profile\" after positive week 28 clinical data, UBS said in a Wednesday note.Oruka's ORKA-001 increased its Psoriasis Area and Severity Index-100 score, which represents the complete resolution of psoriasis, to 71% from 64% in week 16. This compares favorably with rival product, AbbVie's  Skyrizi, which rose to 53% from 43% in the same period, UBS analysts said.The safety data was also consistent with prior data, as treatment-emergent adverse events were 36% in the period of week 16 to 28, compared with 51% during week zero to 16. There were also no injection site reactions and no impact of anti-drug antibodies on safety, efficacy and pharmacokinetics, the analysts noted.The analysts said they are confident in the company's multiple additional readouts later in the year to be positive, \"given the de-risking provided by previous datasets\".UBS' rating on the company's stock is b","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0029864427.USD","PPH","BK4585","ORKA","JDOC","AGNG","LU1093756168.USD","MEDX","LU2237443549.SGD","IE000WAW04H5.SGD","LU0124676726.USD","LU0256863811.USD","LU0795875169.SGD","RXL","LU0320765646.SGD","VHT","BK4588","IXJ","LU0198837287.USD","LU0985320562.USD","LU0256863902.USD","IE00BN8TJ469.HKD","FHLC","FTXH","TRUH","LU1003077747.HKD","SG9999001440.SGD","IE00B19Z3B42.SGD","BK4007","LU0114720955.EUR","LU1934455863.HKD","LU2133065610.SGD","LU0511384066.AUD","IE000F7OJYX1.SGD","LENZ","IYH","IE00BVYPNW00.USD","LU0432979614.USD","GLAM","LU0289961442.SGD","LU0395794307.EUR","XLV","SG9999015986.USD","IE00BLSP4239.USD","PJP","BK4550","LU0211327993.USD","ABBV","LU2129689514.USD","IE00BSNM7G36.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670149441","title":"S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT","url":"https://stock-news.laohu8.com/highlight/detail?id=2670149441","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670149441?lang=en_us&edition=fundamental","pubTime":"2026-09-25 00:00","pubTimestamp":1790265608,"startTime":"0","endTime":"0","summary":"BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDTS&P 500.SPXTop PerformersPercent ChangeEverpure IncP.N+18.4%Charles River Laboratories International, Inc.CRL.N+5.2%Valero Energy CorpVLO.N+4.0%Illumina IncILMN.OQ+3.7%Eli Lilly and CompanyLLY.N+3.4%Bottom PerformersPercent ChangeMGM Resorts InternationalMGM.N-10.2%Gen Digital Inc.GEN.OQ-8.2%First Solar, Inc.FSLR.OQ-7.5%Rollins IncROL.N-6.2%Bloom Energy CorporationBE.N-5.9%As of 12:00 p.m., the S&P 500.SPXlost 33.07 points, or 0.43%, to 7,673.06 and had posted 10 new 52-week highs and 36 new lows.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nL8N45G1NE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","SG9999014880.SGD","LU2023250504.SGD","IE00B1BXHZ80.USD","SG9999015945.SGD","PXI","LU1366192091.USD","XDTE","LU2750360997.AUD","LU0390134368.USD","LU1035775433.USD","LU0323239441.USD","RSPN","LU1280957306.USD","LU2357125470.USD","LU2361044949.HKD","LU0106261372.USD","BMAY","MHIP","LU0353189680.USD","SPXU","IE0005OL40V9.USD","BE","ILDR","JEPI","LU0820561818.USD","FSLR","LU0203201768.USD","VEU","SPMO","GNOM","LU2168564495.EUR","IXJ","VHT","LU1983299162.USD","BK4121","LU0079474960.USD","LU2462157665.USD","DBSC","LU0354030438.USD","LU0882574139.USD","SGXZ31699556.SGD","LU2249611893.SGD","LU0889565916.HKD","LU2125909759.SGD","IE00BKDWB100.SGD","SMAX","IE00B3CCJ633.GBP","SPLV","SDS","IYH","LU2108987350.USD","LU1868836591.USD","IE00BGHQF417.EUR","LU0943347566.SGD","SG9999001440.SGD","SG9999001176.USD","LU2324357040.USD","BK4097","GSLC","FENY","IE00BK4W5M84.HKD","LU2168564222.USD","ELIL","IHE","LU2272731600.USD","LU0353189763.USD","IE00B2Q91V27.USD","BEX","HRTS","LU0964807845.USD","ITOT","LU2063271972.USD","RSPG","LU2294711713.HKD","IE00B2B36J28.USD","LU2552382058.USD","LU1551013425.SGD","IE00BFTCPJ56.SGD","LU2461242641.AUD","SGXZ57979304.SGD","IE0002141913.USD","LU0957808578.USD","NOBL","LU0823434740.USD","LU2756315318.SGD","SPY","LU2028103732.USD","IE00B3CCJ963.GBP","IVW","SPUU","LU0061475181.USD","LU0476273544.USD","LU0114720955.EUR","LU0256863811.USD","PPH","LU1988902786.USD",".SPX","LU0345781412.USD","LU1145028129.USD","LU1992135472.HKD","LU2491049909.HKD","SG9999015986.USD","IBAT","VTV","LU1868836914.USD","SFY","LU2286300806.USD","IE00BJT1NW94.SGD","LU0432979614.USD","SCHB","MEDI","IVV","LU2125909916.SGD","BK4585","SPXS","SG9999017495.SGD","IE00BWXC8680.SGD","LU1023059063.AUD","LU0345770308.USD","YSPY","CTEC","LU0124384867.USD","SH","TMED","LU2750360641.GBP","SGXZ51526630.SGD","LU2237443549.SGD","ICLN","LU2543165471.USD","LU2471134879.HKD","BK4170","TSPY","LU0354030511.USD","HYDR","LU2089283258.USD","BK4150","LLY","LU1868837300.USD","PXE","LU1623119135.USD","IE00BK4W5L77.USD","LU0320765992.SGD","BK4138","LU0456855351.SGD","SG9999014906.USD","AGNG","CURE","LU0724618433.USD","LU0154245756.USD","LU0640476718.USD","BEC","IE00B4JS1V06.HKD","LU0630314457.HKD","PJP","XLV","LU0256863902.USD","BK4596","LU0689472784.USD","LU1720051108.HKD","SG9999015952.SGD","LU2237443382.USD","ILMN","SPHD","LU1291159041.SGD","LU2111349929.HKD","LU0320765059.SGD","IE00B4R5TH58.HKD","LU0109394709.USD","LU2746668974.SGD","LU0316494557.USD","LU0300736492.USD","SG9999018865.SGD","XLE","LU2089984988.USD","LU0368265418.SGD","LU0133085943.USD","LU0312595415.SGD","LU1983299246.USD","LU2322448957.HKD","PUL","BK4535","RSPU","SPHQ","LU2756315664.SGD","LU0757428866.USD","LU0266013472.USD","SG9999001176.SGD","LU2456880835.USD","LU2087625088.SGD","LU2272731782.SGD","LU1815336760.USD","LU0788109394.HKD","SPYM","BEZ","FTXH","GPIX","LU1992135399.USD","LLII","BK4541","LU1548497426.USD","LU2471134796.USD","SGXZ99366536.SGD","BK4533","LU2211815571.USD","LU1923622291.USD","RXL","TRUN","CNRG","ZAP","LU2552382215.SGD","LU1629891620.HKD","IE00BKPKM429.USD","LU1712237335.SGD","LU1814569148.SGD","SPYQ","TRUH","IE00BFSS7M15.SGD","MEDX","LU1815336091.USD","LU0417517546.SGD","LU0238689110.USD","LU0210536198.USD","LU0385154629.USD","LU0882574055.USD","LU1978683503.SGD","IJR","IE0009355771.USD","LU0820561909.HKD","LU2272731865.HKD","IE00BFMHRM44.USD","SPUS","LU2746668461.USD","LU0158827781.USD","LU2473716301.USD","LU2491050154.USD","GNMX","LU1585245621.USD","LU2298322129.HKD","IE00B7KXQ091.USD","LU2023250330.USD","LU0820562030.AUD","EGGY","LU0058720904.USD","LU0471298694.HKD","LU0466842654.USD","WATS","BK4561","LU0823434583.USD","IVE","LU0672654240.SGD","LU2023251221.USD","LU2168564065.EUR","LU0289739699.SGD","LU2357305700.SGD","LU2360106947.USD","LU0345780950.USD","IE00B2PGVK34.USD","UPRO","SPYV","IE0004445239.USD","LU0109391861.USD","VCLN","LU0198837287.USD","LU0266512127.USD","LU1267930730.SGD","IE0001KFT4U8.USD","IE00BJJMRZ35.SGD","LLYZ","P","GDOC","LU0708995401.HKD","LU2271345857.HKD","LU0158827948.USD","LU1232071149.USD","LU0823421416.USD","LU1720051017.SGD","LU2106854487.HKD","LU1974910355.USD","BK4588","VOOG","HIBL","LU0786609619.USD","RSP","LU0006306889.USD","VTWG","LU0323240290.USD","LU1691799644.USD","DRLL","IE00BJLML261.HKD","VV","LU2168563687.JPY","ELIS","LU1551013342.USD","LU1093756325.SGD","LU2168564149.EUR","CRL","XLG","LU1127390331.HKD","IE0009354923.USD","IE0004445015.USD","LU0122376428.USD","LU2237443465.HKD","LLYX","MMAX","IE00BFSS8Q28.SGD","XYLD","LU2048586759.USD","LU0094547139.USD","IJH","LU0823414478.USD","LU0174119429.USD","LU1917777945.USD","LU2264538146.SGD","SCHX","LU2237443622.USD","LU0266512473.USD","SSO","LU2361045086.USD","VTI","BK4516","LU0096364046.USD","LU0097036916.USD","SPYD","SPYU","BEG","LU1323610961.USD","LU0225283273.USD","LU2506951792.HKD","LU0170899867.USD","BK4007","IYE","SG9999018857.SGD","LU2211814178.USD","SPYG","LU1069344957.HKD","LU2236285917.USD","LU2468319806.SGD","HIBS","TAN","SPGP","UPGR","VBK","WDNA","LU1868837136.USD","ETFT","GEN","ODDZ","CANC","ROL","OZEM","LU0471298777.SGD","LU0444971666.USD","LU1430594728.SGD","THNR","LU1989771016.USD","GXPE","SPDN","LU0029874061.USD","LU0128526141.USD","LU1061106388.HKD","SG9999013999.USD","BK4519","SGXZ81514606.USD","ALLW","RSPA","LU0234572021.USD","BK4534","SG9999014898.SGD","LU2112291526.USD","LU0823416689.USD","SMOG","SPXL","LU1093756168.USD","LU0787776722.HKD","GB00BDT5M118.USD","SG9999015978.USD","IE00BGHQF524.EUR","LU1064131342.USD","BK4120","LU2265009873.SGD","IE00B775H168.HKD","BK4141","LU2602419157.SGD","ACWI","IE00BJJMRX11.SGD","LU0683600562.USD","CRAK","SG9999014914.USD","BK4599","IE00B1XK9C88.USD","BK4530","MOAT","LU2237443978.SGD","BK4182","VLO","LU2471134523.USD","WEEI","FRNW","LU0444973449.USD","LU2417539215.USD","LU2462591350.SGD","LU2361044865.SGD","LU1868836757.USD","LU2896262040.SGD","LU1979441026.SGD","LU2237438978.USD","LU1804176565.USD","IE00BN29S564.USD","LU0203202063.USD","LU0323591593.USD","LU2237443895.HKD","LU2322448791.USD","LU2089284900.SGD","BK4548","LU0154245673.USD","SPYH","LU1571399168.USD","DMAX","MGM","LU0456854461.SGD","IE00BSNM7G36.USD","VOO","LU2213496289.HKD","LU2471134952.CNY","BK4581","FHLC","TNGY","LU0345770993.USD","LU0823421333.USD","JDOC","LU1642822529.SGD","SIMS","LU2491050071.SGD","LU2552382132.HKD","LU0823414551.USD","LU0122379950.USD","IEO","IE00BJJMRY28.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669499070","title":"FDA Advisors Said it Should Approve the Grail Multicancer Blood Test. the Stock Rises Sharply.","url":"https://stock-news.laohu8.com/highlight/detail?id=2669499070","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669499070?lang=en_us&edition=fundamental","pubTime":"2026-09-24 22:52","pubTimestamp":1790261520,"startTime":"0","endTime":"0","summary":"Mizuho's Bradley Bowers thinks the boost will be substantial. He wrote Tuesday that sales doubled in the launch years of other cancer-screening products-like colon cancer stool test Cologuard from the Exact Sciences unit of Abbott, or the colon cancer blood test Shield from Guardant Health.Galleri screens a person's blood sample for bits of DNA showing features typical of cancer cells. It tells you if it has found a general signal of cancer somewhere in your body-\"Cancer Signal Detected\"-and makes its best guess at the kind of tissue where the cancer is hiding.Clinical trials showed Galleri can detect cancers for which there is no standard screen, such as cancer of the ovary or pancreas. Grail's two big clinical trials showed that it rarely tells you that you have cancer when you don't. When you do have cancer, the test finds it on average about 50% of the 60% of the time.That is good performance, compared with other widely used screens, like the mammogram. Grail plans to tell customer","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","BK4082","LU1721429402.USD","TMED","BK4585","LU1721429741.USD","BK4196","LU2112291526.USD","LU2237957811.SGD","LU2324357040.USD","GNOM","PJP","LU0320765992.SGD","SG9999002224.SGD","SGXZ41872573.SGD","LU0320765489.SGD","BK4581","IE00B4R5TH58.HKD","LU1061106388.HKD","GNMX","LU0889565916.HKD","LU0882574055.USD","PTH","HELX","SG9999004303.SGD","BK4551","GRAL","LU2089984988.USD","EKG","LABU","IE0002141913.USD","IE00B2B36J28.USD","IHI","LU1670627923.USD","LU1989763690.USD","BK4588","FFOX","LU0868494617.USD","SG9999002232.USD","LU0122379950.USD","SGXZ23171101.USD","BK4568","GH","LU0289739699.SGD","LU0211331839.USD","BK4535","BK4139","LU1691799644.USD","ABT","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669149622","title":"Eli Lilly and Co Stock (LLY) Moved Up by 3.73% on Sep 24: A Full Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2669149622","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669149622?lang=en_us&edition=fundamental","pubTime":"2026-09-24 22:15","pubTimestamp":1790259318,"startTime":"0","endTime":"0","summary":"• FDA approved Eli Lilly's once-weekly basal insulin Onswik for type 2 diabetes.\n• Eli Lilly reported $65.18B annual revenue and $20.64B net profit.\n• Analysts rate the stock as Buy with an average price target of $1306.81.","market":"hk","thumbnail":"https://resource.tradingkey.com/uploads/20260204/eli-lilly-721e93ffd5ee465b8c55167d9246fe47.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260204/eli-lilly-721e93ffd5ee465b8c55167d9246fe47.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262185188-market-movers-lly-20260924","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015952.SGD","LU2461242641.AUD","LU1868837136.USD","LU0323591593.USD","LU2237443978.SGD","LU0109391861.USD","LU2063271972.USD","ILDR","LU2237443549.SGD","OZEM","IE00BJJMRY28.SGD","LU0061475181.USD","IE0001KFT4U8.USD","IE00B7KXQ091.USD","LU2237443622.USD","LU2271345857.HKD","IE00BKPKM429.USD","IXJ","LU0210536198.USD","LU1629891620.HKD","LU0823416689.USD","LU2552382215.SGD","LU2602419157.SGD","LU1988902786.USD","LU0203202063.USD","LU1366192091.USD","LU1974910355.USD","LU0640476718.USD","LU2023250330.USD","FTXH","LU2089283258.USD","BK4534","MHIP","LU2211815571.USD","LU1868836757.USD","LU0266013472.USD","LU1814569148.SGD","LU2168564222.USD","LU1979441026.SGD","IYH","LU1267930730.SGD","SG9999015945.SGD","IE00BKDWB100.SGD","SG9999015986.USD","LU1989771016.USD","LU2756315318.SGD","LU1868836591.USD","LU2361044949.HKD","LU2237443895.HKD","IE00BJJMRX11.SGD","LU1548497426.USD","CANC","LU2237438978.USD","LU0823434583.USD","LU0353189680.USD","MEDX","LU2357305700.SGD","LU0122379950.USD","LU0096364046.USD","LU0786609619.USD","SGXZ99366536.SGD","IE00B4R5TH58.HKD","SG9999001176.SGD","BK4007","IE00BFSS8Q28.SGD","IE00BK4W5M84.HKD","LU2361044865.SGD","IE00B1BXHZ80.USD","IE00BFSS7M15.SGD","LU0320765059.SGD","LU1023059063.AUD","LU2462591350.SGD","LLII","LU0316494557.USD","LU0820561909.HKD","TRUH","WDNA","IE00B1XK9C88.USD","LU1551013425.SGD","BK4516","LU1035775433.USD","LU2237443465.HKD","LU1069344957.HKD","IE00BN29S564.USD","LU1057294990.SGD","LU2168564065.EUR","LU0006306889.USD","LU0385154629.USD","BK4581","LU2168563687.JPY","LU2028103732.USD","SG9999001176.USD","LU2168564149.EUR","LU1280957306.USD","LU1093756325.SGD","LLYZ","IE00BJLML261.HKD","LU2462157665.USD","SGXZ51526630.SGD","LU2471134523.USD","LU0225283273.USD","LU0689472784.USD","LU1127390331.HKD","FHLC","LU1691799644.USD","LU0787776722.HKD","PJP","LU0320765992.SGD","LU1064131342.USD","LU2756315664.SGD","LU2896262040.SGD","LU2471134879.HKD","IE0004445015.USD","SGXZ31699556.SGD","LU0672654240.SGD","LU1323610961.USD","LU2417539215.USD","LU0289739699.SGD","LU2168564495.EUR","LU0820562030.AUD","LU2468319806.SGD","LU2264538146.SGD","SG9999014914.USD","IE00B2B36J28.USD","LU0823434740.USD","GDOC","LU0708995401.HKD","IE00BJT1NW94.SGD","LU0354030511.USD","LU1061106388.HKD","IE0005OL40V9.USD","LU0882574055.USD","BK4585","LU2491050154.USD","LU0432979614.USD","IE00BWXC8680.SGD","SG9999015978.USD","SG9999018865.SGD","LU2491050071.SGD","LU0198837287.USD","LU2265009873.SGD","HRTS","LU1551013342.USD","LU0106261372.USD","SG9999013999.USD","LU0256863902.USD","LU0964807845.USD","AGNG","SG9999014880.SGD","BK4588","LU0889565916.HKD","IE00B4JS1V06.HKD","LU2023251221.USD","SG9999017495.SGD","LU1623119135.USD","LU0471298777.SGD","LU2106854487.HKD","LU2108987350.USD","LU0079474960.USD","LU2746668461.USD","VHT","LU2750360997.AUD","LU0353189763.USD","LU1720051108.HKD","LU0471298694.HKD","LU0109394709.USD","LU0114720955.EUR","SG9999014906.USD","LU0174119429.USD","SG9999018857.SGD","LU2023250504.SGD","IHE","LU1145028129.USD","BK4599","ELIL","LU1093756168.USD","LU0094547139.USD","IE0004445239.USD","LU0456855351.SGD","LU2324357040.USD","LU2491049909.HKD","LU0354030438.USD","RXL","LU2552382132.HKD","LU0238689110.USD","LU2089284900.SGD","IE00BK4W5L77.USD","LU2750360641.GBP","LU0417517546.SGD","THNR","ELIS","LU0158827948.USD","LU1868837300.USD","LU2111349929.HKD","LU0058720904.USD","TMED","LLYX","IE00BFTCPJ56.SGD","GB00BDT5M118.USD","SGXZ57979304.SGD","LU0466842654.USD","LU0882574139.USD","LU1291159041.SGD","LU1917777945.USD","LU1983299246.USD","LU0158827781.USD","LU2237443382.USD","LU2361045086.USD","LU2746668974.SGD","LU0256863811.USD","LU0820561818.USD","BK4533","LU0097036916.USD","IE00B775H168.HKD","LU2456880835.USD","LU2213496289.HKD","LLY","LU1804176565.USD","LU1712237335.SGD","LU0943347566.SGD","LU0133085943.USD","XLV","LU0234572021.USD","LU1232071149.USD","LU0683600562.USD","LU2112291526.USD","SG9999014898.SGD","IE0002141913.USD","LU0203201768.USD","IE00BJJMRZ35.SGD","PPH","CURE","MEDI","LU2471134952.CNY","SGXZ81514606.USD","LU2087625088.SGD","LU2360106947.USD","LU1868836914.USD","LU2089984988.USD","LU2471134796.USD","IE0009355771.USD","LU0345770308.USD","LU1720051017.SGD","LU2236285917.USD","LU2552382058.USD","LU0345770993.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669149540","title":"Lilly's Next-Gen Obesity Efforts Could Tip Scales Further in Its Favor, Citi Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2669149540","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669149540?lang=en_us&edition=fundamental","pubTime":"2026-09-24 21:46","pubTimestamp":1790257597,"startTime":"0","endTime":"0","summary":"BUZZ-Lilly's next-gen obesity efforts could tip scales further in its favor, Citi says** Eli LillyLLY.Nis expected to present mid-stage data next week on eloralintide, its next-generation obesity drug candidate, in combination with its blockbuster weight-loss drug Zepbound, chemically known as tirzepatide** Citi analysts say the data will be a test of whether eloralintide can extend tirzepatide's efficacy without compromising tolerability or persistence** Eloralintide belongs to the class of drugs that mimic the pancreatic hormone amylin with the potential of less severe side effects than the popular GLP-1 class of drugs** Citi says 16 to 18% weight loss would be a \"solid readout with over 18% being a clean win to further diversify Lilly's obesity portfolio, expand coverage across patient needs, and provide greater treatment flexibility\"** A 9-milligram dose of eloralintide had helped patients lose about20.1%or 21.3 kgs in a mid-stage study last year** Up to last close, LLY up ~7% YTD","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nL4N45G155:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FHLC","LU2468319806.SGD","SG9999015986.USD","LU0823434583.USD","IE00B775H168.HKD","IXJ","AGNG","LU1712237335.SGD","SG9999015945.SGD","LU0345770308.USD","LU1691799644.USD","LU1057294990.SGD","SG9999015952.SGD","SG9999013999.USD","IE00B1XK9C88.USD","LU0061475181.USD","LU2211815571.USD","SGXZ81514606.USD","IE00BJJMRY28.SGD","LU1145028129.USD","LU1323610961.USD","IE00BK4W5M84.HKD","LU2112291526.USD","LU0106261372.USD","LU0256863811.USD","LU1917777945.USD","LU2462591350.SGD","LU2106854487.HKD","LU2471134879.HKD","LU1093756168.USD","BK4581","SG9999014880.SGD","LU1988902786.USD","LU0266013472.USD","LU2168564149.EUR","LU2265009873.SGD","LU0058720904.USD","LU0456855351.SGD","LU0316494557.USD","LU0256863902.USD","IE0009355771.USD","LU2237443465.HKD","LU2237443382.USD","HRTS","LU2213496289.HKD","IE00B7KXQ091.USD","LLYX","LU2237443978.SGD","LU1127390331.HKD","SG9999017495.SGD","IE0001KFT4U8.USD","LU0471298694.HKD","LU2471134952.CNY","LU0964807845.USD","ELIL","SG9999018857.SGD","LU2750360997.AUD","LU0289739699.SGD","LU2108987350.USD","SG9999001176.USD","LU1280957306.USD","LU0158827948.USD","LU0672654240.SGD","PPH","SG9999001176.SGD","XLV","LU0097036916.USD","IE00BFSS8Q28.SGD","LU1868836914.USD","LU2552382058.USD","LU0238689110.USD","LU1720051108.HKD","SGXZ31699556.SGD","IE00BKPKM429.USD","LU0198837287.USD","LU0353189680.USD","LU0354030438.USD","LU1551013425.SGD","BK4007","LU0889565916.HKD","IE00B4R5TH58.HKD","LU1069344957.HKD","IHE","LU2023250504.SGD","LU2471134523.USD","LU0786609619.USD","IE00BN29S564.USD","LU2750360641.GBP","LU1868836757.USD","LU0203201768.USD","LU0385154629.USD","LU2360106947.USD","LU2756315664.SGD","IE00BJJMRZ35.SGD","LU2089284900.SGD","LU0079474960.USD","LU2552382215.SGD","LU0158827781.USD","RXL","LU2552382132.HKD","LU0323591593.USD","LU1974910355.USD","SG9999018865.SGD","LU2168564222.USD","LU1623119135.USD","BK4533","MEDX","LU0225283273.USD","GDOC","LU2089283258.USD","ILDR","LU1232071149.USD","LU1979441026.SGD","LU2063271972.USD","LU2746668974.SGD","LLII","LU1804176565.USD","LU0320765992.SGD","LU1814569148.SGD","LU0114720955.EUR","IE00BFTCPJ56.SGD","LU0787776722.HKD","LU1291159041.SGD","IE00BK4W5L77.USD","LU1064131342.USD","LU2023251221.USD","OZEM","LU1023059063.AUD","LLYZ","CURE","LU1868836591.USD","LU2462157665.USD","LU2471134796.USD","LU1035775433.USD","LLY","LU1989771016.USD","LU2361044949.HKD","LU2361045086.USD","SG9999015978.USD","SGXZ51526630.SGD","LU2361044865.SGD","LU0471298777.SGD","SGXZ99366536.SGD","LU2491049909.HKD","LU2602419157.SGD","LU0320765059.SGD","LU1983299246.USD","LU1366192091.USD","BK4599","IE0005OL40V9.USD","LU0210536198.USD","IE0004445015.USD","IYH","LU2028103732.USD","LU0122379950.USD","LU2324357040.USD","LU1548497426.USD","LU0174119429.USD","LU0234572021.USD","LU0109394709.USD","IE00BJLML261.HKD","LU2168563687.JPY","LU0353189763.USD","IE00BJT1NW94.SGD","LU0882574139.USD","SGXZ57979304.SGD","LU2357305700.SGD","LU2237443622.USD","LU1061106388.HKD","BK4588","PJP","LU2756315318.SGD","LU0823416689.USD","TRUH","LU0820561818.USD","IE00BWXC8680.SGD","LU0354030511.USD","LU0432979614.USD","LU2456880835.USD","WDNA","BK4585","LU2237443895.HKD","JDOC","LU0094547139.USD","IE00BFSS7M15.SGD","LU0683600562.USD","BK4534","LU0823434740.USD","LU2237438978.USD","SG9999014914.USD","LU0640476718.USD","FTXH","LU2896262040.SGD","MEDI","VHT","IE00B1BXHZ80.USD","LU2264538146.SGD","LU1629891620.HKD","LU2271345857.HKD","LU2168564065.EUR","LU2461242641.AUD","LU0006306889.USD","IE0004445239.USD","LU0345770993.USD","THNR","LU0417517546.SGD","IE0002141913.USD","LU2236285917.USD","LU0466842654.USD","LU2237443549.SGD","ELIS","IE00B4JS1V06.HKD","LU1868837300.USD","LU0820561909.HKD","IE00B2B36J28.USD","LU0689472784.USD","LU2746668461.USD","TMED","LU1093756325.SGD","SG9999014898.SGD","LU2087625088.SGD","LU2089984988.USD","LU0203202063.USD","IE00BKDWB100.SGD","LU2491050071.SGD","GB00BDT5M118.USD","LU0708995401.HKD","LU2023250330.USD","LU2417539215.USD","LU0133085943.USD","CANC","LU0820562030.AUD","LU2111349929.HKD","BK4516","IE00BJJMRX11.SGD","LU1720051017.SGD","LU2491050154.USD","MHIP","LU1551013342.USD","SG9999014906.USD","LU1267930730.SGD","LU0109391861.USD","LU2168564495.EUR","LU0096364046.USD","LU1868837136.USD","LU0943347566.SGD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":15,"pageCount":10,"totalSize":293,"code":"91000000","status":"200"}]}}